MPO and COVID-19: In addition, a prospective study of 279 individuals showed that plasma MPO levels in nonsevere (NS), severe (S), and postacute phase (PAP) COVID-19 patients were significantly different from the levels in healthy individuals, and plasma MPO levels had high diagnostic power for the disease severity of COVID-19 [26].